BTIG, Medical

BTIG cuts Outset Medical target to $3, maintains Buy rating
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease from the previous $4.00, while continuing to recommend a Buy rating for the stock.
Outset Medical price target lowered to $3 from $4 at BTIG
BTIG lowered the firm’s price target on Outset Medical (OM) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model
Outset Medical Inc (OM) Stock Trading Recap
On Wednesday, Outset Medical Inc (OM) stock saw a decline, ending the day at $0.76 which represents a decrease of $-0.05 or -6.17% from the prior close of $0.81. The stock opened at $0.83 and touched a low of $0.71 during the day, reaching a high of $0.83. The volume of shares traded was 1.87 million exceeding the average volume of 1.03 million.
KeyBanc cuts Inspire Medical stock target to $234
KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision follows Inspire Medical (TASE:PMCN)'s pre-announcement of its fourth-quarter results and initial guidance for the year 2025.
Inspire Medical price target lowered to $234 from $236 at KeyBanc
KeyBanc lowered the firm’s price target on Inspire Medical (INSP) to $234 from $236 and keeps an Overweight rating on the shares after the
Outset Medical adjusts stockholder voting rules
Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, ...
Outset Medical announces $169M private placement financing
Outset Medical (OM) has entered into a definitive securities purchase agreement for a private placement of 843,908 shares of its Series A ...
Nasdaq19d
Outset Medical, Inc. CEO Leslie Trigg to Present at 43rd Annual J.P. Morgan Healthcare Conference
Outset Medical is set to present at the prestigious 43rd annual J.P. Morgan Healthcare conference, which could enhance visibility and credibility within the healthcare sector. The company's ...
bovnews3mon
RBC Capital Mkts Issues Sector Perform Rating for Outset Medical Inc (OM) Stock
RBC Capital Mkts has recently reduced Outset Medical Inc (OM) stock to Sector Perform rating, as announced on August 8, 2024, according to Finviz. Earlier, on June 21, 2024, RBC Capital Mkts had ...
Wall Street Journal2y
Outset Medical Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Nasdaq21d
Outset Medical Secures New Financing and Debt Facility
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...
Benzinga.com2y
Outset Medical (NASDAQ:OM) Stock, Short Interest Report
Short interest in Outset Medical Inc (NASDAQ:OM) decreased during the last reporting period, falling from 2.80M to 2.62M. This put 5.83% of the company's publicly available shares short.
Investing19d
Outset Medical's SWOT analysis: stock poised for growth amid transformation
Outset Medical's financial trajectory has shown signs of improvement, despite facing challenges. In its Q3 2024 earnings report, the company surpassed expectations and subsequently raised its 2024 ...
Yahoo Finance19d
Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...
Analysts Are Bullish on Top Healthcare Stocks: Gilead Sciences (GILD), Outset Medical (OM)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD – Research Report) and ...